A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...

For procedures like BBL, fat is usually extracted from the patient via liposuction and then reinjected into the desired area ...

About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so ...

Explore this year's advancements in gastroenterology biosimilars, highlighting key FDA approvals and market dynamics ...

Samsung Bioepis Co. Ltd. has announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', ...

After a weak first half, the drug and biotech sector has recovered in the past 2-3 months, with most large drugmakers signing ...

Novo Nordisk carries a Zacks Rank #5 (Strong Sell), whereas Amgen carries a Zacks Rank #3 (Hold) at present, which makes AMGN ...

SEOUL, Dec. 23 (Yonhap) -- Samsung Bioepis Co., a biosimilar drug developer under Samsung Group, said Tuesday it has received ...

Samsung Bioepis Co., Ltd. today announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', a biosimilar referencing Stelara1 (ustekinumab), developed by Samsung ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma (TM), a ...

Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO' has been granted marketing approval in Japan First marketing approval under the partnership with NIPRO CORPORATION, paving the way ...